As filed with the Securities and Exchange Commission on August 28, 1997
Registration Statement No. 333-3730
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
_________________________
Anika Therapeutics, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Massachusetts 04-3145961
(State of Incorporation) (I.R.S. Employer Identification Number)
236 West Cummings Park
Woburn, Massachusetts 01801
(617) 932-6616
(Address, Including Zip Code, and Telephone Number, Including Area Code, of
Registrant's Principal Executive Offices)
_______________________________
J. Melville Engle
President
Anika Therapeutics, Inc.
236 West Cummings Park
Woburn, Massachusetts 01801
(617) 932-6616
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code,
of Agent For Service)
____________________________
With copies to:
H. DAVID HENKEN, ESQ.
Goodwin, Procter & Hoar LLP
Exchange Place
53 State Street
Boston, Massachusetts 02109-2881
(617) 570-1000
Approximate date of commencement of proposed sale to the public: N/A
If the only securities being registered on this form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box.
If any of the securities being registered on this form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or
interest reinvestment plans, check the following box. x
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following
box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. ______________
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. ______________
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box.
____________________________
<PAGE>
ANIKA THERAPEUTICS, INC.
DEREGISTRATION OF SECURITIES
-------------------------
Anika Therapeutics, Inc. (the "Registrant") previously filed Registration
Statement No. 333-3730 on Form S-3 (the "Registration Statement") covering
1,658,700 shares of its common stock $ .01 par value per share (the "Common
Stock"). The offering contemplated by the Registration Statement was
terminated on August 28, 1997. Accordingly, the Registrant hereby files this
Post-Effective Amendment No. 1 to the Registration Statement to deregister a
total of 203,700 shares of its Common Stock originally registered by the
Registration Statement which remained unsold as of the termination of the
offering.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended (the
"Securities Act"),Anika Therapeutics, Inc. certifies that it has duly caused
this Post-Effective Amendment No. 1 to the Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in Boston,
Massachusetts, on the 26th day of August, 1997.
ANIKA THERAPEUTICS, INC.
By:/s/ Sean F. Moran
------------------
Sean F. Moran
Vice President of Finance and Treasurer
(Principal Financial and Accounting
Officer)
Pursuant to the requirements of the Securities Act, this Post-Effective
Amendment No. 1 to the Registration Statement has been signed by the
following persons in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signature Capacity Date
<S> <C> <C>
* Chairman of the Board August 26, 1997
David A. Swann
* Director August 26, 1997
Joseph L. Bower
* Director August 26, 1997
Eugene A. Davidson
* Director August 26, 1997
Jonathan D. Donaldson
* Director August 26, 1997
Samuel McKay
* Director August 26, 1997
Harvey Sadow
* Director August 26, 1997
Steven E. Wheeler
President (Principal Executive August 27, 1997
/s/ J. Melville Engle Officer) and Director
---------------------
J. Melville Engle
Vice President of Finance and August 27, 1997
/s/ Sean F. Moran Treasurer (Principal Financial
----------------- and Accounting Officer)
Sean F. Moran
*By: /s/ Sean F. Moran
-----------------
Sean F. Moran
Attorney-in-fact
</TABLE>
